EUVIMEDEUVIMED entdecken
Systematische Übersicht

Cannabis‐based products for medicinal use in dogs and cats: a systematic review

N Moreno-López iD, C Moreno-López, P Amariles iD

Journal of Small Animal Practice · 2025-12 · 66 (12) · 855-870

DOI: 10.1111/jsap.13913 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Small Animal Practice, online erschienen am 14.07.2025. Verfasst von N Moreno-López und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research Group on Pharmaceutical Promotion and Prevention, University of Antioquia, UdeA, Medellin, Colombia. Hauptthemen laut MEDLINE: Cat Diseases, Dog Diseases, Medical Marijuana, Cannabinoids. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Universidad de Antioquia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Cannabis‐based products for medicinal use, also referred to as cannabinoid‐containing products, particularly those containing cannabidiol as the primary active constituent, have shown to be a possible alternative in treating various health conditions in companion animals. Thus, this systematic review aims to synthesise and analyse the available data on the efficacy/effectiveness and safety of cannabis‐based products for medicinal use in dogs and cats to assist in clinical decision‐making. Materials and Methods A systematic review was conducted across PubMed, LILACS, Scopus, and Google Scholar from February 2014 to February 2024. The search strategy included both MeSH terms and free‐text keywords related to medical cannabis, including Medical Marijuana, Cannabis and Cannabaceae, combined with terms referring to domestic cats and dogs. Additionally, title/abstract keywords, including Cannab (as a truncated term), were used to retrieve literature on cannabinoids and their therapeutic applications.

Results

Twenty‐two articles were identified examining cannabidiol‐based formulations for osteoarthritis, epilepsy, atopic dermatitis, postsurgical pain, and behavioural issues. Cannabis‐based products for medicinal use with cannabidiol as the primary active constituent demonstrated improvements in pain, behaviour, and seizures, with no serious adverse events. However, research on their use in cats is limited to two studies. Clinical Significance While promising, the long‐term efficacy/effectiveness, optimal dosages, and safety of cannabis‐based products for medicinal use remain unclear. Further studies are needed to confirm their therapeutic potential and ensure safe veterinary use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cat DiseasesDog DiseasesMedical MarijuanaCannabinoidsAnimalsCatsDogsCannabidiol

Substanzen

Medical MarijuanaCannabidiolCannabinoids

Autor:innen und Institutionen

  • Research Group on Pharmaceutical Promotion and Prevention, University of Antioquia, UdeA, Medellin, Colombia.
  • Health Economics Group, University of Antioquia, UdeA, Medellin, Colombia.
  • Research Group on Pharmaceutical Care, University of Granada, Granada, Spain.

ORCID-Profile: N Moreno-López, P Amariles

Förderung

  • Universidad de Antioquia

Zitieren

APA

Moreno-López, N., Moreno-López, C., & Amariles, P. (2025). Cannabis‐based products for medicinal use in dogs and cats: a systematic review. Journal of Small Animal Practice, 66(12), 855-870. https://doi.org/10.1111/jsap.13913

Vancouver

Moreno-López N, Moreno-López C, Amariles P. Cannabis‐based products for medicinal use in dogs and cats: a systematic review. Journal of Small Animal Practice. 2025;66(12):855-870. doi:10.1111/jsap.13913

BibTeX
@article{MorenoLpez2025,
  author = {Moreno-López, N and Moreno-López, C and Amariles, P},
  title = {Cannabis‐based products for medicinal use in dogs and cats: a systematic review},
  journal = {Journal of Small Animal Practice},
  year = {2025},
  volume = {66},
  number = {12},
  pages = {855--870},
  doi = {10.1111/jsap.13913}
}
Kostenlos starten →